ArticleScientific reports2025
Bisphenol A suppresses colon epithelial cell responses via G
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Bisphenol A promotes esophageal carcinogenesis by activating the MMP1-PCOLCE regulatory axis and remodeling the tumor immune microenvironment.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Engineering of cell line assembled enteric organoid for enterovirus infection.Archives of virology · 2026Article
- Environmental pollutants and the gut microbiota: mechanistic links from exposure to systemic disease.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Bisphenol A (BPA) is a non-steroidal endocrine-disrupting chemical compound with applications in the production of epoxy resins and polycarbonates. Accumulating evidence suggests that BPA damages various organs and tissues, including those of the reproductive, immune, and neuroendocrine systems. However, the mechanisms by which BPA affects the intestinal tract have not been fully elucidated. We explored the adverse effects of BPA on human colonic epithelial cells in vitro by performing comprehensive viability, proliferation, invasion, and migration assays on HCT 116 and HCT-8 cells. BPA suppressed the proliferation of both cell types by regulating cell cycle progression and modulating the mitogen-activated protein kinase and phosphatidylinositol 3-kinase/protein kinase B pathways. Furthermore, BPA treatment significantly reduced the induction of matrix metalloproteinases-2 and -9 by inhibiting the binding activity of specificity protein-1, nuclear factor kappa B, and activator protein-1, thereby interfering with cell migration and invasion. This BPA-induced regulation of colonic epithelial cell proliferation, migration, invasion, and MAPK/AKT pathway was reversed by silencing p21WAF1 with siRNA. Collectively, our data indicate that BPA inhibits the proliferation and mobility of human colonic epithelial cells via p21WAF1 induction. This study provides valuable information into the precise mechanisms underlying the adverse effects of BPA on colonic epithelial cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.